Metronidazole (Catalan Wikipedia)

Analysis of information sources in references of the Wikipedia article "Metronidazole" in Catalan language version.

refsWebsite

Global rank Catalan rank

10doi.org

2^nd place

6^th place

9nih.gov

4^th place

7^th place

4web.archive.org

1^st place

3who.int

195^th place

155^th place

2drugs.com

399^th place

487^th place

2google.ca

838^th place

356^th place

1fda.gov

447^th place

656^th place

1tga.gov.au

3,984^th place

9,719^th place

1pfizer.com

low place

1iarc.fr

4,025^th place

2,735^th place

1europa.eu

68^th place

49^th place

1farad.org

low place

1medscape.com

719^th place

610^th place

1dvm360.com

low place

doi.org

dx.doi.org

Cohen, Stuart H.; Gerding, Dale N.; Johnson, Stuart; Kelly, Ciaran P.; Loo, Vivian G.; McDonald, L. Clifford; Pepin, Jacques; Wilcox, Mark H. «Clinical Practice Guidelines for Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)». Infection Control and Hospital Epidemiology, 31, 5, maig 2010, pàg. 431–455. DOI: 10.1086/651706. PMID: 20307191.
Joesoef, MR; Schmid, GP; Hillier, SL «Bacterial vaginosis: review of treatment options and potential clinical indications for therapy.». Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 28 Suppl 1, Jan 1999, pàg. S57-65. DOI: 10.1086/514725. PMID: 10028110.
; Bakkanagari, S. R.; Moorthi, K. M.; Davis, M. B. «A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity». Clinical Infectious Diseases, 45, 3, 2007, pàg. 302–7. DOI: 10.1086/519265. PMID: 17599306.
; Parschalk, B; Hasenhündl, M; Hirschl, A. M.; Graninger, W «Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea». Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 22, 5, 1996, pàg. 813–8. DOI: 10.1093/clinids/22.5.813. PMID: 8722937.
; Gerding, D. N.; Olson, M. M.; Peterson, L. R.; Gebhard, R. L.; Schwartz, M. J.; Lee Jr, J. T. «Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis». Lancet, 2, 8358, 1983, pàg. 1043–6. DOI: 10.1016/s0140-6736(83)91036-x. PMID: 6138597.
Bendesky, A; Menéndez, D; Ostrosky-Wegman, P «Is metronidazole carcinogenic?». Mutation Research, 511, 2, juny 2002, pàg. 133–44. DOI: 10.1016/S1383-5742(02)00007-8. PMID: 12052431.
Williams, C. S.; Woodcock, K. R. «Do ethanol and metronidazole interact to produce a disulfiram-like reaction?». The Annals of Pharmacotherapy, 34, 2, 2000, pàg. 255–7. DOI: 10.1345/aph.19118. PMID: 10676835. «the authors of all the reports presumed the metronidazole-ethanol reaction to be an established pharmacologic fact. None provided evidence that could justify their conclusions»
Ebel, K.; Koehler, H.; Gamer, A. O.; Jäckh, R.. Ullmann's Encyclopedia of Industrial Chemistry (en anglès). Weinheim, Alemanya: Wiley-VCH, 2005. DOI 10.1002/14356007.a13_661. «Imidazole and Derivatives» CS1 maint: Multiple names: authors list (link)
Actor, P.; Chow, A. W.; Dutko, F. J.; McKinlay, M. A.. Ullmann's Encyclopedia of Industrial Chemistry (en anglès). Weinheim, Alemanya: Wiley-VCH, 2005. DOI 10.1002/14356007.a06_173. «Chemotherapeutics» CS1 maint: Multiple names: authors list (link)
Kraft, M. Ya.; Kochergin, P. M.; Tsyganova, A. M.; Shlikhunova, V. S. «Synthesis of metronidazole from ethylenediamine». Pharmaceutical Chemistry Journal, 23, 10, 1989, pàg. 861–863. DOI: 10.1007/BF00764821.

drugs.com

«Metronidazole». The American Society of Health-System Pharmacists. [Consulta: 31 juliol 2015].
«Metronidazole». Drugs.com.

dvm360.com

veterinarynews.dvm360.com

Hoskins, J. D. «Advances in managing inflammatory bowel disease». DVM Newsmagazine, Oct 1, 2001 [Consulta: 28 desembre 2013]. Arxivat 2013-12-31 a Wayback Machine. «Còpia arxivada». Arxivat de l'original el 2013-12-31. [Consulta: 27 abril 2016].

europa.eu

emea.europa.eu

Committee for Medicinal Products for Veterinary Use (CVMP). «Metronidazole Summary Report EMEA/MRL/173/96-FINAL» (pdf). European Medicines Agency, juliol 1997. Arxivat de l'original el 2007-07-10. [Consulta: 11 desembre 2009].

farad.org

«Restricted and Prohibited Drugs in Food Animals». Food Animal Residue Avoidance Databank. U.S. Food and Drug Administration, 2013. [Consulta: 28 desembre 2013].

fda.gov

accessdata.fda.gov

FDA Drug Safety Datasheet for Flagyl, http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/012623s061lbl.pdf

google.ca

books.google.ca

Corey, E.J.. Drug discovery practices, processes, and perspectives. Hoboken, N.J.: John Wiley & Sons, 2013, p. 27. ISBN 9781118354469.
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8. Elsevier Health Sciences, 2014, p. 2753. ISBN 9780323263733.

iarc.fr

monographs.iarc.fr

International Agency for Research on Cancer (IARC). «Agents Classified by the IARC Monographs, Volumes 1–100» (PHP). World Health Organization, maig 2010. [Consulta: 6 juny 2010].

medscape.com

reference.medscape.com

«Flagyl, Flagyl ER (metronidazole) dosing, indications, interactions, adverse effects, and more». Medscape Reference. WebMD. Arxivat de l'original el 7 abril 2014. [Consulta: 3 abril 2014].

nih.gov

ncbi.nlm.nih.gov

Cohen, Stuart H.; Gerding, Dale N.; Johnson, Stuart; Kelly, Ciaran P.; Loo, Vivian G.; McDonald, L. Clifford; Pepin, Jacques; Wilcox, Mark H. «Clinical Practice Guidelines for Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA)». Infection Control and Hospital Epidemiology, 31, 5, maig 2010, pàg. 431–455. DOI: 10.1086/651706. PMID: 20307191.
Joesoef, MR; Schmid, GP; Hillier, SL «Bacterial vaginosis: review of treatment options and potential clinical indications for therapy.». Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 28 Suppl 1, Jan 1999, pàg. S57-65. DOI: 10.1086/514725. PMID: 10028110.
; Spence, M. R.; Rein, M. F.; Danzig, M. R.; McCormack, W. M. «Multicenter comparison of clotrimazole vaginal tablets, oral metronidazole, and vaginal suppositories containing sulfanilamide, aminacrine hydrochloride, and allantoin in the treatment of symptomatic trichomoniasis». Sexually transmitted diseases, 24, 3, 1997, pàg. 156–60. PMID: 9132982.
; Bakkanagari, S. R.; Moorthi, K. M.; Davis, M. B. «A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity». Clinical Infectious Diseases, 45, 3, 2007, pàg. 302–7. DOI: 10.1086/519265. PMID: 17599306.
; Parschalk, B; Hasenhündl, M; Hirschl, A. M.; Graninger, W «Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea». Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 22, 5, 1996, pàg. 813–8. DOI: 10.1093/clinids/22.5.813. PMID: 8722937.
; Gerding, D. N.; Olson, M. M.; Peterson, L. R.; Gebhard, R. L.; Schwartz, M. J.; Lee Jr, J. T. «Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis». Lancet, 2, 8358, 1983, pàg. 1043–6. DOI: 10.1016/s0140-6736(83)91036-x. PMID: 6138597.
Bendesky, A; Menéndez, D; Ostrosky-Wegman, P «Is metronidazole carcinogenic?». Mutation Research, 511, 2, juny 2002, pàg. 133–44. DOI: 10.1016/S1383-5742(02)00007-8. PMID: 12052431.
Williams, C. S.; Woodcock, K. R. «Do ethanol and metronidazole interact to produce a disulfiram-like reaction?». The Annals of Pharmacotherapy, 34, 2, 2000, pàg. 255–7. DOI: 10.1345/aph.19118. PMID: 10676835. «the authors of all the reports presumed the metronidazole-ethanol reaction to be an established pharmacologic fact. None provided evidence that could justify their conclusions»

ntp.niehs.nih.gov

«Metronidazole CAS No. 443-48-1» (pdf). Report on Carcinogens, Twelfth Edition (2011). U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program. [Consulta: 28 octubre 2011].

pfizer.com

«Flagyl 375 U.S. Prescribing Information» (pdf). Pfizer. Arxivat de l'original el 2008-08-07. [Consulta: 27 abril 2016].

tga.gov.au

ebs.tga.gov.au

«Metrogyl Metronidazole Product Information» (PDF). TGA eBusiness Services. Alphapharm Pty Limited, 08-05-2013. [Consulta: 3 abril 2014].

web.archive.org

«Flagyl 375 U.S. Prescribing Information» (pdf). Pfizer. Arxivat de l'original el 2008-08-07. [Consulta: 27 abril 2016].
Committee for Medicinal Products for Veterinary Use (CVMP). «Metronidazole Summary Report EMEA/MRL/173/96-FINAL» (pdf). European Medicines Agency, juliol 1997. Arxivat de l'original el 2007-07-10. [Consulta: 11 desembre 2009].
«Flagyl, Flagyl ER (metronidazole) dosing, indications, interactions, adverse effects, and more». Medscape Reference. WebMD. Arxivat de l'original el 7 abril 2014. [Consulta: 3 abril 2014].
Hoskins, J. D. «Advances in managing inflammatory bowel disease». DVM Newsmagazine, Oct 1, 2001 [Consulta: 28 desembre 2013]. Arxivat 2013-12-31 a Wayback Machine. «Còpia arxivada». Arxivat de l'original el 2013-12-31. [Consulta: 27 abril 2016].

who.int

apps.who.int

«WHO Model List of Essential Medicines» (PDF). World Health Organization, octubre 2013. [Consulta: 22 abril 2014].
«Trichomoniasis treatment in women», 28-07-2003. [Consulta: 1r agost 2015].
«Sources and Prices of Selected Medicines and Diagnostics for People Living with HIV/AIDS». World Health Organization, 2005. [Consulta: 1r agost 2015].